Pharmaceutical giant AstraZeneca has agreed to develop, manufacture and distribute a potential coronavirus vaccine with the prestigious University of Oxford.
Professor Sir John Bell, the Regius Professor of Medicine at Oxford University, said the deal would be a “major force” in the struggle against future pandemics.
“We believe that together we will be in a strong position to start immunising against coronavirus once we have an effective approved vaccine,” he said.
“Sadly, the risk of new pandemics will always be with us and the new research centre will enhance the world’s preparedness and our speed of reaction the next time we face such a challenge,” Prof Bell added.
Experts at Oxford are testing the effectiveness of potential vaccine ChAdOx1 nCoV-19, which has been given to more than 320 people since the first human trial last week.
They say the would-be vaccine is safe, although there have been reports of a temperature, flu-like symptoms, headaches and a sore arm in the short term.
Phase one clinical trial last week used health volunteers aged 18-55, with data potentially available next month. Late-stage trials should take place by the middle of the years.
Pascal Soriot, the CEO of AstraZeneca, said the agreement would combine Oxford’s history of vaccinology and his firms expertise in manufacturing and distributing pharmaceuticals.
“As Covid-19 continues its grip on the world, the need for a vaccine to defeat the virus is urgent. Our hope is that, by joining forces, we can accelerate the globalisation of a vaccine to combat the virus and protect people from the deadliest pandemic in a generation.”
The study at Oxford of volunteers in southern England will use up to 1,100 participants with some receiving the would-be vaccine and others something else.
Key facilities
- Olympic-size swimming pool with a split bulkhead for multi-use configurations, including water polo and 50m/25m training lanes
- Premier League-standard football pitch
- 400m Olympic running track
- NBA-spec basketball court with auditorium
- 600-seat auditorium
- Spaces for historical and cultural exploration
- An elevated football field that doubles as a helipad
- Specialist robotics and science laboratories
- AR and VR-enabled learning centres
- Disruption Lab and Research Centre for developing entrepreneurial skills
Company name: Play:Date
Launched: March 2017 on UAE Mother’s Day
Founder: Shamim Kassibawi
Based: Dubai with operations in the UAE and US
Sector: Tech
Size: 20 employees
Stage of funding: Seed
Investors: Three founders (two silent co-founders) and one venture capital fund
Sole survivors
- Cecelia Crocker was on board Northwest Airlines Flight 255 in 1987 when it crashed in Detroit, killing 154 people, including her parents and brother. The plane had hit a light pole on take off
- George Lamson Jr, from Minnesota, was on a Galaxy Airlines flight that crashed in Reno in 1985, killing 68 people. His entire seat was launched out of the plane
- Bahia Bakari, then 12, survived when a Yemenia Airways flight crashed near the Comoros in 2009, killing 152. She was found clinging to wreckage after floating in the ocean for 13 hours.
- Jim Polehinke was the co-pilot and sole survivor of a 2006 Comair flight that crashed in Lexington, Kentucky, killing 49.
Arrogate's winning run
1. Maiden Special Weight, Santa Anita Park, June 5, 2016
2. Allowance Optional Claiming, Santa Anita Park, June 24, 2016
3. Allowance Optional Claiming, Del Mar, August 4, 2016
4. Travers Stakes, Saratoga, August 27, 2016
5. Breeders' Cup Classic, Santa Anita Park, November 5, 2016
6. Pegasus World Cup, Gulfstream Park, January 28, 2017
7. Dubai World Cup, Meydan Racecourse, March 25, 2017
